[PDF][PDF] Optimal agonist/antagonist combinations maintain receptor response by preventing rapid b1-adrenergic receptor desensitization
R Lanzara - Int. J. Pharm, 2005 - academia.edu
… calculated to prevent receptor desensitization, which has … or as part of an agonist'antagonist
combination. The Iso and Dob … earliest events of receptor desensitization can be modeled …
combination. The Iso and Dob … earliest events of receptor desensitization can be modeled …
[HTML][HTML] Preventing Rapid Receptor Desensitization at the β1-Adrenergic Receptor with Agonist/Antagonist Combinations
R Lanzara - CPS: medichem, 2003 - bio-balance.com
… agonist/antagonist combination solution to prevent desensitization. Both the Iso/Met and
Dob/Met agonist/antagonist combination … the earliest events of receptor desensitization can be …
Dob/Met agonist/antagonist combination … the earliest events of receptor desensitization can be …
Preventing Rapid Receptor Desensitization at the Β-Adrenergic Receptor with Agonist/Antagonist Combinations
R Lanzara - Science Direct Working Paper, 2003 - papers.ssrn.com
… agonist/antagonist combination solution to prevent desensitization. Both the Iso/Met and
Dob/Met agonist/antagonist combination … the earliest events of receptor desensitization can be …
Dob/Met agonist/antagonist combination … the earliest events of receptor desensitization can be …
[PDF][PDF] Preventing Rapid Receptor Desensitization at the>-Adrenergic Receptor with Agonist/Antagonist Combinations
R Lanzara - bio-balance.com
… agonist/antagonist combination solution to prevent desensitization. Both the Iso/Met and
Dob/Met agonist/antagonist combination … the earliest events of receptor desensitization can be …
Dob/Met agonist/antagonist combination … the earliest events of receptor desensitization can be …
Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis
CA Tamminga, A Carlsson - Current Drug Targets-CNS & …, 2002 - ingentaconnect.com
… Moreover, the proportions of an agonist/antagonist combination can be varied to achieve an
… of these activities (presumably due to receptor desensitization) when administered over the …
… of these activities (presumably due to receptor desensitization) when administered over the …
[HTML][HTML] The two formyl peptide receptors differently regulate GPR84-mediated neutrophil NADPH oxidase activity
J Mårtensson, M Sundqvist, A Manandhar… - Journal of Innate …, 2021 - karger.com
… for each agonist/antagonist combination is shown. c Naïve … experiments for each
agonist/antagonist combination is shown… terminated through homologous receptor desensitization …
agonist/antagonist combination is shown… terminated through homologous receptor desensitization …
The Two Formyl Peptide Receptors Differently Regulate GPR84-Mediated Neutrophil NADPH Oxidase Activity
JMMSA Manandharb, LLL Zhangc, TUX Xiec… - 2021 - karger.com
… for each agonist/antagonist combination is shown. c Naïve … experiments for each
agonist/antagonist combination is shown… terminated through homologous receptor desensitization …
agonist/antagonist combination is shown… terminated through homologous receptor desensitization …
Partial agonism of dopamine, serotonin and opiate receptors for psychiatry
F Yocca, CA Altar - Drug Discovery Today: Therapeutic Strategies, 2006 - Elsevier
… It is frequently administered with naloxone as an opioid partial agonist–antagonist combination
… , reducing the potential for receptor desensitization. When excessive neurotransmission …
… , reducing the potential for receptor desensitization. When excessive neurotransmission …
[HTML][HTML] 5-HT2A receptor activation normalizes exaggerated fear behavior in p-chlorophenylalanine (PCPA)-treated rats
… Factor 2 (4 drug conditions, within groups) was the agonist/antagonist combination given
on … inhibition of fear may also involve receptor desensitization. While the amygdala seems a …
on … inhibition of fear may also involve receptor desensitization. While the amygdala seems a …
[HTML][HTML] Gonadotropin-releasing hormone receptors in prostate cancer: molecular aspects and biological functions
F Fontana, M Marzagalli, M Montagnani Marelli… - International journal of …, 2020 - mdpi.com
… Interestingly, according to Uemura and coworkers, GnRH agonist/antagonist combination
treatments represent the mainstay therapeutic approach in CRPC patients in Japan [185]. …
treatments represent the mainstay therapeutic approach in CRPC patients in Japan [185]. …
Related searches
- agonist efficacy receptor desensitization
- agonist antagonist interaction model
- specific inhibitors receptor desensitization
- chronic administration agonists and antagonists
- partial agonists of dopamine receptors
- formyl peptide receptor agonists
- possible mechanisms receptor partial agonists
- fear processing receptor agonist
- partial truths receptor desensitization
- fuller picture receptor desensitization
- multiple pathways receptor desensitization
- rational design receptor partial agonists
- agonist efficacy functional desensitization
- partial agonist human dopamine d2 receptors